Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morita Kagaku Kogyo is a Japanese specialty chemical company recognized as a global pioneer in the development and commercialization of Stevia-based sweeteners. Founded in 1947, the company was the first in the world to successfully extract and commercialize steviol glycosides from the Stevia rebaudiana plant in the 1970s. Its business focuses on the research, cultivation, and production of high-purity natural sweeteners and plant-derived ingredients for the food, beverage, and health industries. The company maintains a significant intellectual property portfolio regarding Stevia extraction and purification technologies. Morita Kagaku Kogyo plays a critical role in the global supply chain for sugar-reduction solutions aimed at addressing metabolic health issues like diabetes and obesity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morita Kagaku Kogyo.